Overview
- Federal prosecutors unsealed charges late Tuesday that accuse Swapnadip Roy and Vicky Ramancha of running a scheme to smuggle counterfeit Ozempic into the United States.
- The pair are charged with conspiracy, multiple counts of smuggling, and selling or possessing counterfeit drugs and face up to 71 years in prison if convicted.
- Prosecutors say the operation ran from July 2023 through April 2024 and moved thousands of counterfeit units from unauthorized manufacturers in China into U.S. distributors.
- Court records allege the fakes included copied packaging, false serial numbers, pen labels, inserts and needles, and that shipments continued after the FDA seized counterfeit product and warned the public in December 2023.
- Authorities say they used international tools including an INTERPOL Red Notice and extradition from Italy to bring Roy to Tampa, the FDA’s Office of Criminal Investigations is investigating, and the case could prompt tighter scrutiny of GLP-1 drug supply chains.